Intravascular Ultrasound Parameters Associated With Stent Thrombosis After Drug-Eluting Stent Deployment

American Journal of Cardiology

Volumn 100, Issue 4, 2007, Pages 615-620

  Okabe, Teruo ^a   Mintz, Gary S ^b   Buch, Ashesh N ^a   Roy, Probal ^a   Hong, Young Joon ^a   Smith, Kimberly A ^a   Torguson, Rebecca ^a   Gevorkian, Natalie ^a   Xue, Zhenyi ^a   Satler, Lowell F ^a   Kent, Kenneth M ^a   Pichard, Augusto D ^a   Weissman, Neil J ^a   Waksman, Ron ^a  

^a WASHINGTON HOSPITAL CENTER   (United States)

^b CARDIOVASCULAR RESEARCH FOUNDATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLOPIDOGREL; PACLITAXEL; RAPAMYCIN;

ADULT; AGED; ARTICLE; CHRONIC KIDNEY FAILURE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG ELUTING STENT; FEMALE; HUMAN; INTRAVASCULAR ULTRASOUND; LOADING DRUG DOSE; MALE; PRIORITY JOURNAL; RESTENOSIS; THROMBOSIS;

AGED; COATED MATERIALS, BIOCOMPATIBLE; CORONARY ANGIOGRAPHY; CORONARY STENOSIS; CORONARY THROMBOSIS; ENDOSONOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; MYOCARDIAL REVASCULARIZATION; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSTHESIS FAILURE; RETROSPECTIVE STUDIES; SIROLIMUS; STENTS;

EID: 34547657959     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2007.03.072     Document Type: Article

References (29)

1. Morice M.C., Serruys P.W., Sousa J.E., Fajadet J., Ban Hayashi E., Perin M., Colombo A., Schuler G., Barragan P., Guagliumi G., Molnar F., Falotico R., and RAVEL Study Group. Randomized study with the sirolimus-coated Bx velocity balloon-expandable stent in the treatment of patients with de novo native coronary artery lesions. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med 346 (2002) 1773-1780
2. Moses J.W., Leon M.B., Popma J.J., Fitzgerald P.J., Holmes D.R., O'Shaughnessy C., Caputo R.P., Kereiakes D.J., Williams D.O., Teirstein P.S., Jaeger J.L., Kuntz R.E., and SIRIUS Investigators. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 349 (2003) 1315-1323
3. Colombo A., Drzewiecki J., Banning A., Grube E., Hauptmann K., Silber S., Dudek D., Fort S., Schiele F., Zmudka K., Guagliumi G., Russell M.E., and TAXUS II Study Group. Randomized study to assess the effectiveness of slow- and moderate-release polymer-based paclitaxel-eluting stents for coronary artery lesions. Circulation 108 (2003) 788-794
4. Hong M.K., Mintz G.S., Lee C.W., Song J.M., Han K.H., Kang D.H., Song J.K., Kim J.J., Weissman N.J., Fearnot N.E., Park S.W., Park S.J., and ASian Paclitaxel-Eluting Stent Clinical Trial. Paclitaxel coating reduces in-stent intimal hyperplasia in human coronary arteries: a serial volumetric intravascular ultrasound analysis from the ASian Paclitaxel-Eluting Stent Clinical Trial (ASPECT). Circulation 107 (2003) 517-520
5. Grube E., Silber S., Hauptmann K.E., Mueller R., Buellesfeld L., Gerckens U., and Russell M.E. TAXUS I six- and twelve-month results from a randomized, double-blind trial on a slow-release paclitaxel-eluting stent for de novo coronary lesions. Circulation 107 (2003) 38-42
6. Ardissino D., Cavallini C., Bramucci E., Indolfi C., Marzocchi A., Manari A., Angeloni G., Carosio G., Bonizzoni E., Colusso S., Repetto M., Merlini P.A., and SES-SMART Investigators. Sirolimus-eluting vs uncoated stents for prevention of restenosis in small coronary arteries: a randomized controlled trial. JAMA 292 (2004) 2727-2734
7. Gershlick A., De Scheerder I., Chevalier B., Stephens-Lloyd A., Camenzind E., Vrints C., Reifart N., Missault L., Goy J.J., Brinker J.A., et al. Inhibition of restenosis with a paclitaxel-eluting, polymer-free coronary stent: the European evaluation of pacliTaxel Eluting Stent (ELUTES) trial. Circulation 109 (2004) 487-493
8. Iakovou I., Scmidt T., Bonizzoni E., Ge L., Sangiorgi G.M., Stankovic G., Airoldi F., Chieffo A., Montorfano M., Carlino M., et al. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA 293 (2005) 2126-2130
9. Kuchulakanti P.K., Chu W.W., Torguson R., Ohlmann P., Rha S.W., Clavijo L.C., Kim S.W., Bui A., Gevorkian N., Xue Z., et al. Correlates and long-term outcomes of angiographically proven stent thrombosis with sirolimus- and paclitaxel-eluting stents. Circulation 113 (2006) 1108-1113
10. Park D.W., Park S.W., Park K.H., Lee B.K., Kim Y.H., Lee C.W., Hong M.K., Kim J.J., and Park S.J. Frequency of and risk factors for stent thrombosis after drug-eluting stent implantation during long-term follow-up. Am J Cardiol 98 (2006) 352-356
11. Moreno R., Fernandez C., Hernandez R., Alfonso F., Angiolillo D.J., Sabate M., Escaned J., Banuelos C., Fernandez-Ortiz A., and Macaya C. Drug-eluting stent thrombosis. Results from a pooled analysis including 10 randomized studies. J Am Coll Cardiol 45 (2005) 954-959
12. Waters R.E., Kandzari D.E., Phillips H.R., Crawford L.E., and Sketch Jr. M.H. Late thrombosis following treatment of in-stent restenosis with drug-eluting stents after discontinuation of antiplatelet therapy. Catheter Cardiovasc Interv 65 (2005) 520-524
13. Sonoda S., Morino Y., Ako J., Terashima M., Hassan A.H., Bonneau H.N., Leon M.B., Moses J.W., Yock P.G., Honda Y., Kuntz R.E., Fitzgerald P.J., and SIRIUS Investigators. Impact of final stent dimensions on long-term results following sirolimus-eluting stent implantation: serial intravascular ultrasound analysis from the SIRIUS trial. J Am Coll Cardiol 43 (2004) 1959-1963
14. Fujii K., Carlier S.G., Mintz G.S., Yang Y.M., Moussa I., Weisz G., Dangas G., Mehran R., Lansky A.J., Kreps E.M., et al. Stent underexpansion and residual reference segment stenosis are related to stent thrombosis after sirolimus-eluting stent implantation: an intravascular ultrasound study. J Am Coll Cardiol 45 (2005) 995-998
15. Virmani R., Guagliumi G., Farb A., Musumeci G., Grieco N., Motta T., Mihalcsik L., Tespili M., Valsecchi O., and Kolodgie F.D. Localized hypersensitivity and late coronary thrombosis secondary to a sirolimus-eluting stent. Should we be cautious?. Circulation 109 (2004) 701-705
16. Jeremias A., Sylvia B., Bridges J., Kirtane A.J., Bigelow B., Pinto D.S., Ho K.K., Cohen D.J., Garcia L.A., Cutlip D.E., and Carrozza Jr. J.P. Stent thrombosis after successful sirolimus-eluting stent implantation. Circulation 109 (2004) 1930-1932
17. McFadden E.P., Stabile E., Regar E., Cheneau E., Ong A.T., Kinnaird T., Suddath W.O., Weissman N.J., Torguson R., Kent K.M., et al. Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy. Lancet 364 (2004) 1519-1521
18. Cheneau E., Leborgne L., Mintz G.S., Kotani J., Pichard A.D., Satler L.F., Canos D., Castagna M., Weissman N.J., and Waksman R. Predictors of subacute stent thrombosis: results of a systematic intravascular ultrasound study. Circulation 108 (2003) 43-47
19. Argulian E., Patel A.D., Abramson J.L., Kulkarni A., Champney K., Palmer S., Weintraub W., Wenger N.K., and Vaccarino V. Gender differences in short-term cardiovascular outcomes after percutaneous coronary interventions. Am J Cardiol 98 (2006) 48-53
20. Sakurai R., Ako J., Morino Y., Sonoda S., Kaneda H., Terashima M., Hassan A.H., Leon M.B., Moses J.W., Popma J.J., et al., SIRIUS Trial Investigators. Predictors of edge stenosis following sirolimus-eluting stent deployment (a quantitative intravascular ultrasound analysis from the SIRIUS trial). Am J Cardiol 96 (2005) 1251-1253
21. Alfonso F., Suarez A., Angiolillo D.J., Sabate M., Escaned J., Moreno R., Hernandez R., Banuelos C., and Macaya C. Findings of intravascular ultrasound during acute stent thrombosis. Heart 90 (2004) 1455-1459
22. Uren N.G., Schwarzacher S.P., Metz J.A., Lee D.P., Honda Y., Yeung A.C., Fitzgerald P.J., Yock P.G., and POST Registry Investigators. Predictors and outcomes of stent thrombosis. An intravascular ultrasound registry. Eur Heart J 23 (2002) 124-132
23. Feres F., Costa J.R., and Abizaid A. Very late thrombosis after drug-eluting stents. Catheter Cardiovasc Interv 68 (2006) 83-88
24. Farb A., Burke A.P., Kolodgie F.D., and Virmani R. Pathological mechanisms of fatal late coronary stent thrombosis in humans. Circulation 108 (2003) 1701-1706
25. Kim S.W., Mintz G.S., Ohlmann P., Hassani S.E., Fernandez S., Lu L., Chu W.W., Escolar E., Kuchulakanti P.K., Weigold G., et al. Frequency and severity of plaque prolapse within Cypher and Taxus stents as determined by sequential intravascular ultrasound analysis. Am J Cardiol 98 (2006) 1206-1211
26. Takebayashi H., Mintz G.S., Carlier S.G., Kobayashi Y., Fujii K., Yasuda T., Costa R.A., Moussa I., Dangas G.D., Mehran R., et al. Nonuniform strut distribution correlates with more neointimal hyperplasia after sirolimus-eluting stent implantation. Circulation 110 (2004) 3430-3434
27. Sianos G., Hofma S., Ligthart J.M., Saia F., Hoye A., Lemos P.A., and Serruys P.W. Stent fracture and restenosis in the drug-eluting stent era. Cathet Cardiovasc Interv 61 (2006) 111-116
28. Hong M.K., Mintz G.S., Lee C.W., Park D.W., Park K.M., Lee B.K., Kim Y.H., Song J.M., Han K.H., Kang D.H., et al. Late stent malapposition after drug-eluting stent implantation. An intravascular ultrasound analysis with long-term follow-up. Circulation 113 (2006) 414-419
29. Futamatsu H., Sabate M., Angiolillo D.J., Jimenez-Quevedo P., Corros C., Morikawa-Futamatsu K., Alfonso F., Jiang J., Cervinka P., Hernandez-Antolin R., et al. Characterization of plaque prolapse after drug-eluting stent implantation in diabetic patients. A three-dimensional volumetric intravascular ultrasound outcome study. J Am Coll Cardiol 48 (2006) 1139-1145